EndaCof DH and Insulin glargine and lixisenatide
Determining the interaction of EndaCof DH and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / dihydrocodeine / phenylephrine
Brand name:
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- EndaCof DH-Insulin glargine and lixisenatide Subcutaneous
- EndaCof DH-Insulin glargine, recombinant Subcutaneous
- EndaCof DH-Insulin glulisine
- EndaCof DH-Insulin Glulisine (Cartridges and Pens)
- EndaCof DH-Insulin Glulisine (Vials)
- EndaCof DH-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Endacof HC
- Insulin glargine and lixisenatide-EndaCof-AC
- Insulin glargine and lixisenatide-EndaCof-C
- Insulin glargine and lixisenatide-EndaCof-DM
- Insulin glargine and lixisenatide-EndaCof-PD
- Insulin glargine and lixisenatide-Endal CD Syrup